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Production of the equine influenza vaccine using a
baculovirus expression system in insect cell lines
Part III: Downstream & process control
Saioa Arza, Helena García, Oriol Cabau, Laia Puig
GLOBAL OBJECTIVE
Design of an industrial bioprocess plant with the simulator
SuperPro Designer for the production of the equine influenza
vaccine using a baculovirus expression system in insect cell
lines, and subsequent analysis of its sustainability.
To guarantee the quality of the final product, the
process will be performed following the Good
Manufacturing Practices (GMP) standards.
In order to attain the fulfillment of the norms GMP a
program Quality-by-Design (QbD) that will allow to control
each point of the process efficiently has been designed.
GMP PROCESS QbD PROGRAM
BACULOVIRUS EXPRESSION SYSTEM
PROCESS FLUX 
DIAGRAM CONTROL AND INSTRUMENTATION
In order to guarantee the Quality-by-Design (QbD)
program, instrumentation for process control has
been installed. Details for the Bioreactor control
and instrumentation:
Process critical control loops: 
• Air sterilization using HEPA filters 
• Virus inactivation monitoring by virus  
quantification
• Protein production and purification
In case one of the critical variables go out of the limits 
established the necessary measures would be carried 
out to go back to the normality. A closed control loop 
example: 
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This is a simulation of the hole
process that has been obtained from
the block diagram using the process
simulator SuperPro Designer.
YIELD 
70%
UV light damages the DNA irreversibly
eliminating the viral infectivity. Thymine dimers
are an example of the damages that appears in
the genetic material during this treatment.
Thermal or chemical methods discarded for put 
in danger the stability of the protein.
AEX chromatography binds virus and genetic
material due to his negative charge. HA1 do not bind
cause the working pH induces the protein to have a
positive charge in his surface.
As industrially stated, two different stages of viral
clearence are performed.
VIRAL CLEARENCE PROCESS ORGANIZATION
Time organization in three
consecutives batches with a total
duration of 21 days. The critical
step, and consequently the
bottle neck is the bioreaction.
Employers requirement during
three consecutives batches. The
employers demand is higher in
the critical step with a peak of
12 workers.
Process Analytical Technologies (PAT) implementation
Control strategies by means of PAT are implemented to ensure product
quality and operation efficacy in every stage of the downstream process.21 g for each batch. HA1 is
the 98.6% of the total
protein at the end of the
downstream. A highly
purified product has been
obtained.
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